Related Experiment Video

Updated: May 13, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Tubulin: an example of targeted chemotherapy

Jenny Seligmann1, Chris Twelves

  • 1Section of Oncology & Clinical Research, Leeds Institute of Molecular Medicine, St. James' Institute of Oncology, St. James' University Hospital, Leeds, UK.

Future Medicinal Chemistry
|March 8, 2013
PubMed

Insights

Novel microtubule targeting agents (MTAs) are emerging to overcome limitations of traditional chemotherapy. These new agents offer improved efficacy and reduced toxicity for cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Microtubule targeting agents (MTAs) like taxanes and vinca alkaloids are mainstays in cancer chemotherapy.
  • Limitations of current MTAs include hypersensitivity, neurotoxicity, drug resistance, and lack of biomarkers.
  • These limitations necessitate the development of novel MTAs.

Purpose of the Study:

  • To review novel microtubule targeting agents (MTAs) for anticancer therapies.
  • To discuss recent debates on MTA mechanisms of action.
  • To highlight agents in clinical trials and under development.

Main Methods:

  • Review of existing literature on MTAs.
  • Analysis of mechanisms of action for novel agents.
  • Discussion of clinical trial data for promising MTAs.

Main Results:

  • Several novel MTAs show promise, addressing limitations of older drugs.
  • Agents like eribulin, ixabepilone, cabazitaxel, and trastuzumab-DM1 have demonstrated clinical utility.
  • Ongoing research focuses on new generations of MTAs and future therapeutic directions.

Conclusions:

  • Novel MTAs represent a significant advancement in cancer chemotherapy.
  • These agents aim to improve treatment efficacy and patient outcomes.
  • Continued research is crucial for developing next-generation MTAs.

More Related Videos

Optimizing Tubulin Yield from Porcine Brain Tissue06:30

Optimizing Tubulin Yield from Porcine Brain Tissue

Published on: October 11, 2024

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...